He estimated that 75 of people between the ages of 12 and 65 could be getting a bivalent booster at this point and have not taken one.
Those people could go out and get the bivalent booster now to improve their protection, he said.
People under 65 who have already received a single bivalent dose should not yet get another one, said the agency.
Simplifying the Process
The agency said it wants to simplify the COVID vaccination schedule to stop confusion and better prepare for emerging variants.
To that end, the FDAs advisory panel will meet in June to discuss what strains and variants of SARSCoV2 are most likely to be circulating in the fall and winter of 202324.
The committee will recommend which of those should be included in a vaccine, and drugmakers will then prepare the new shot to be given in the fall, Marks said.
Americans under 65 have not taken advantage of getting a bivalent booster to a large extent, Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research, said in a briefing with reporters.
This post was created with our nice and easy submission form. Create your post!